Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Salonpas · Salonpas Arthritis Pain, Salonpas Pain Relief

Other · developed by Hisamitsu Pharmaceutical Co.

Approved FDA
1 Registered trials

What is Salonpas?

Salonpas is a topical patch containing lidocaine 4% applied to the skin for 12 hours to temporarily relieve mild to moderate aches and pains of muscles and joints.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Salonpas Arthritis Pain, Salonpas Pain Relief
Drug type
Other
Therapy area
Musculoskeletal
Developer
Hisamitsu Pharmaceutical Co., Inc.
In trials of
SCLX
FDA status
Approved as Salonpas Arthritis Pain, Salonpas Pain Relief, NDA022029 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Mar 14, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05106400 Phase 1 Healthy Completed SCLX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Healthy

Sources

Updated Oct 3, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.